Matches in SemOpenAlex for { <https://semopenalex.org/work/W4300608506> ?p ?o ?g. }
- W4300608506 endingPage "283" @default.
- W4300608506 startingPage "273" @default.
- W4300608506 abstract "The overexpression or amplification of tumor suppressor and proto-oncogenes are important factors in the progression of breast cancer. Recent attention has focused on the cyclin genes, whose involvement in signal transduction pathways regulate cell cycle progression. The amplification of the cyclins D1 and D3 genes usually leads to loss of normal growth control and is thought to play an important growth regulatory role in tumor development and progression. In this report, we investigate the association of altered cyclin expression with other prognostic indicators (histological grade, lymph node status, estrogen receptor, p53, and c-erbB-2) in the progression of human breast cancer. Surgical tumor specimens were obtained from 16 breast tubular ductal, and invasive ductal carcinomas and grafted onto gnotobiotic nude (nu/nu) mice. The expression diversity and distribution of the localization of the protein products of the c-erbB-2, cyclins Dl and D3, p53, and estrogen receptor were characterized immunohistochemically and the results in the original tumor (T0) were compared with those in the tumors that developed in nude mice (T1) xenografts. The T0 tumors exhibited a diversity of cellular morphology in the tumor matrix and diversity in expression of these proteins. These specific changes were also preserved in the T1 tumors. Whereas 67% of the T1 tumors exhibited high numbers of estrogen receptor-positive nuclei, only 50% of these tumors grew when grafted onto nude mice. The histological grade (14/15 were G2 to G3) and metastatic malignancy in the lymph nodes (10/15) did not appear to be related to tumor growth in the nude mouse. There was no relationship between those tumors which exhibited high percentages of c-erbB-2- and p53-positive cells and growth in nude mice. A strong association (p < 0.001) was observed between the overexpression of cyclin D1 transcripts in the T0 tumors and the continued growth of the T1 tumors in nude mice. In the T1 tumors, both cyclins D1 and D3, estrogen receptor, and p53 were observed in 49% to 86% of the cells of the T1 tumors examined; the number of cells expressing c-erbB-2 protein varied widely in these tumors. The results indicate that the tumor matrix exhibits a diversity in the level of phenotypic expression of genes involved in cellular growth of breast tumors in both the T0 or T1 host environment. Changes in cyclin activity appear to correlate with the vigorous level of breast tumor growth and progression." @default.
- W4300608506 created "2022-10-03" @default.
- W4300608506 creator A5015973137 @default.
- W4300608506 creator A5028382526 @default.
- W4300608506 creator A5037210856 @default.
- W4300608506 creator A5085918918 @default.
- W4300608506 date "1997-04-01" @default.
- W4300608506 modified "2023-10-15" @default.
- W4300608506 title "Expression of Molecular Biomarkers in Primary Breast Tumors Implanted into a Surrogate Host: Increased Levels of Cyclins Correlate with Tumor Progression" @default.
- W4300608506 cites W151192786 @default.
- W4300608506 cites W1963603451 @default.
- W4300608506 cites W1963692923 @default.
- W4300608506 cites W1970731925 @default.
- W4300608506 cites W1970948137 @default.
- W4300608506 cites W1974640412 @default.
- W4300608506 cites W1975818505 @default.
- W4300608506 cites W1979691974 @default.
- W4300608506 cites W1981122694 @default.
- W4300608506 cites W1984690136 @default.
- W4300608506 cites W1990094502 @default.
- W4300608506 cites W1993754091 @default.
- W4300608506 cites W2002109198 @default.
- W4300608506 cites W2003000890 @default.
- W4300608506 cites W2015751996 @default.
- W4300608506 cites W2019285952 @default.
- W4300608506 cites W2023578078 @default.
- W4300608506 cites W2031085992 @default.
- W4300608506 cites W2032998373 @default.
- W4300608506 cites W2042482388 @default.
- W4300608506 cites W2047449304 @default.
- W4300608506 cites W2054122205 @default.
- W4300608506 cites W2054224954 @default.
- W4300608506 cites W2056851331 @default.
- W4300608506 cites W2057533148 @default.
- W4300608506 cites W2058269245 @default.
- W4300608506 cites W2060937867 @default.
- W4300608506 cites W2072382346 @default.
- W4300608506 cites W2074203965 @default.
- W4300608506 cites W2075005332 @default.
- W4300608506 cites W2077837433 @default.
- W4300608506 cites W2078092281 @default.
- W4300608506 cites W2081220090 @default.
- W4300608506 cites W2083182221 @default.
- W4300608506 cites W2085008836 @default.
- W4300608506 cites W2092491717 @default.
- W4300608506 cites W2122222851 @default.
- W4300608506 cites W2150019362 @default.
- W4300608506 cites W2153728059 @default.
- W4300608506 cites W2169679536 @default.
- W4300608506 cites W2321324675 @default.
- W4300608506 cites W4239042856 @default.
- W4300608506 doi "https://doi.org/10.1007/bf03401680" @default.
- W4300608506 hasPublicationYear "1997" @default.
- W4300608506 type Work @default.
- W4300608506 citedByCount "1" @default.
- W4300608506 crossrefType "journal-article" @default.
- W4300608506 hasAuthorship W4300608506A5015973137 @default.
- W4300608506 hasAuthorship W4300608506A5028382526 @default.
- W4300608506 hasAuthorship W4300608506A5037210856 @default.
- W4300608506 hasAuthorship W4300608506A5085918918 @default.
- W4300608506 hasBestOaLocation W43006085061 @default.
- W4300608506 hasConcept C120089663 @default.
- W4300608506 hasConcept C121608353 @default.
- W4300608506 hasConcept C142724271 @default.
- W4300608506 hasConcept C199835354 @default.
- W4300608506 hasConcept C203014093 @default.
- W4300608506 hasConcept C2779013556 @default.
- W4300608506 hasConcept C2779256057 @default.
- W4300608506 hasConcept C2780283643 @default.
- W4300608506 hasConcept C2780849966 @default.
- W4300608506 hasConcept C2781018059 @default.
- W4300608506 hasConcept C29537977 @default.
- W4300608506 hasConcept C502942594 @default.
- W4300608506 hasConcept C530470458 @default.
- W4300608506 hasConcept C54355233 @default.
- W4300608506 hasConcept C71924100 @default.
- W4300608506 hasConcept C84606932 @default.
- W4300608506 hasConcept C86803240 @default.
- W4300608506 hasConceptScore W4300608506C120089663 @default.
- W4300608506 hasConceptScore W4300608506C121608353 @default.
- W4300608506 hasConceptScore W4300608506C142724271 @default.
- W4300608506 hasConceptScore W4300608506C199835354 @default.
- W4300608506 hasConceptScore W4300608506C203014093 @default.
- W4300608506 hasConceptScore W4300608506C2779013556 @default.
- W4300608506 hasConceptScore W4300608506C2779256057 @default.
- W4300608506 hasConceptScore W4300608506C2780283643 @default.
- W4300608506 hasConceptScore W4300608506C2780849966 @default.
- W4300608506 hasConceptScore W4300608506C2781018059 @default.
- W4300608506 hasConceptScore W4300608506C29537977 @default.
- W4300608506 hasConceptScore W4300608506C502942594 @default.
- W4300608506 hasConceptScore W4300608506C530470458 @default.
- W4300608506 hasConceptScore W4300608506C54355233 @default.
- W4300608506 hasConceptScore W4300608506C71924100 @default.
- W4300608506 hasConceptScore W4300608506C84606932 @default.
- W4300608506 hasConceptScore W4300608506C86803240 @default.
- W4300608506 hasIssue "4" @default.
- W4300608506 hasLocation W43006085061 @default.
- W4300608506 hasLocation W43006085062 @default.